Deutsche Bank downgraded Intuitive Surgical (ISRG) to Sell from Hold with a price target of $440, down from $515. Encroachment to Intuitive’s Instruments and Accessories segment by remanufactured instruments is inevitable and likely to be increasingly meaningful over the next few years, the analyst tells investors in a research note. The firm expects a growing number of Intuitive’s customers to explore adoption of remanufactured instruments given the potentially significant profitability gains, citing its discussions with multiple robotic surgery programs. Deutsche believes 46% of Intuitive’s U.S. I&A revenues could be at risk of encroachment by third party-remanufactured devices. Its model assumes no material impact in 2026 but steadily increasing headwinds in 2027 and especially 2028. Intuitive Surgical shares are down 3% to $538.00 in premarket trading.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical downgraded to Sell from Hold at Deutsche Bank
- Intuitive Surgical upgraded to Buy from Hold at Erste Group
- Intuitive Surgical’s Strategic Leadership Transition and DV5 System Launch Support Buy Rating
- Intuitive Surgical price target raised to $650 from $590 at Citi
- Intuitive Surgical call volume above normal and directionally bullish
